Table 4.

IOP reduction at first and second visits.

	Total responders	Nonresponders	Initial responders	Long-term responders	Robust long-termresponders	Super responders
First visit (mmHg)	−2.84 ± 0.30	3.80 ± 0.50	−2.79 ± 0.37	−3.07 ± 0.27	−5.16 ± 0.32	−11.41 ± 0.98
First visit (%)	−14.18 ± 22.16	22.40 ± 17.13	−14.71 ± 12.37	−16.85 ± 10.97	−29.53 ± 9.01	−45.56 ± 15.59
First visit p value	<0.0001	<0.0001	<0.0001	<0.0001	<0.0001	<0.0001
Second visit (mmHg)	−3.01 ± 0.44	0.63 ± 1.08	0.05 ± 0.87	−3.53 ± 0.39	−5.66 ± 0.33	−12.30 ± 1.10
Second visit (%)	−14.94 ± 28.04	4.13 ± 27.99	1.02 ± 32.18	−18.71 ± 11.76	−34.27 ± 9.78	−48.13 ± 16.89
Second visit p value	<0.0001	0.5637	0.9583	<0.0001	<0.0001	<0.0001

mmHg = millimeters of mercury. Mean and SD Rhopressa duration (in days) at instance 1: 55.66 ± 51.89 days. Mean and SD Rhopressa duration (in days) at instance 2: 133.24 ± 77.63 days.